d) at Clairo

Hanover, Lower-Saxony, Germany

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

Automotive, ManufacturingIndustries

Skills

Key technologies and capabilities for this role

Machine OperationMachine SetupMaintenanceTechnical AptitudeTeamworkCommunication

Questions & Answers

Common questions about this position

What is the duration of the Maschinen- und Anlagenführer apprenticeship?

The apprenticeship is a two-year program, with the option to extend to a third year as a Fertigungsmechaniker for good performers.

What qualifications are required for this apprenticeship?

Candidates need a good Hauptschulabschluss, good math skills, technical understanding, manual dexterity, motivation, engagement, initiative, and communication and team skills.

Where is this apprenticeship located and when does it start?

The apprenticeship is at the Hannover location and starts in August 2026.

What does the company offer after completing the apprenticeship?

With good performance, all apprentices have been taken on into permanent employment in recent years.

How should I apply for this apprenticeship?

Apply via the online tool on the career page or by email to Hannover-Ausbildung@clarios.com with your cover letter, resume, and last three school certificates. Contact Lea Waßmann at 0511 3878-2668 for questions.

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free